Pacira Pharmaceuticals (PCRX) PT Raised to $24 at Barclays
Tweet
Share
E-mailGet Alerts PCRX Hot Sheet
Price: $23.00 --0%
Rating Summary:
11 Buy, 16 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 4 | New: 9
Rating Summary:
11 Buy, 16 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 4 | New: 9
Join SI Premium – FREE
Barclays analyst Balaji Prasad raised the price target on Pacira Pharmaceuticals (NASDAQ: PCRX) to $24.00 (from $17.00) while maintaining a Equalweight rating.
You May Also Be Interested In
- Berenberg Upgrades Accelleron Industries AG (ACLN:SW) to Buy
- Stellantis NV (STLA:IM) (STLA) PT Lowered to EUR5 at Citi
- Danske Bank A/S (DANSKE:DC) (DNKEY) PT Raised to DKK340 at JPMorgan
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
